Synthetic biology has been applied to vaccines production, enabling the creation of low-cost, thermostable, cell-free protein synthesis platforms for on-demand production of conjugate vaccines. These platforms can synthesize effective model conjugate vaccines at a low cost, making them more accessible to people worldwide.
The recent breakthrough in synthetic biology has made it possible to produce conjugate vaccines for approximately $0.50 per dose after storage at room temperature and $1.00 per dose after storage at 50°C for up to four weeks. This is a significant development, as it reduces the cost of vaccines production and makes them more accessible to people in low-income countries who may not have access to refrigeration.